Current opinion in hematologyHumansTumor Suppressor Protein p53MutationPrognosisMyeloproliferative Disorders
Navigating prognostic stratification and approach to TP53 -mutated myeloid neoplasms.
Talha Badar, Ayalew Tefferi, Naseema Gangat
Published: 202610.1097/MOH.0000000000000906
Abstract
PURPOSE OF REVIEW: TP53- mutated ( TP53 -MT) myeloid neoplasms (MN) represent one of the most challenging disease subsets due to their distinct pathobiology, frequent association with therapy-related disease, chemo-resistant phenotype, and dismal out…
Preview only. Read the full abstract at the source